ABCL
NASDAQ · Life Sciences Tools & Services
Abcellera Biologics Inc
$3.52
+0.21 (+6.34%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,173.0% upside
Low Target
$32.90
Average Target
$44.81
High Target
$56.58
Current Price
$3.52
Current
$3.52
$3.52
Target
$44.81
$44.81
$32.90
$44.81 avg
$56.58
Scenario Analysis
Bear Case
$32.90
834.7%
Low target
Base Case
$44.81
+1,173.0%
Avg target
Bull Case
$56.58
+1,507.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$6.52
-46.0% from high
52-Week Low
$1.89
+86.2% from low
Target vs 52W High
$44.81
+587.8% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 88% | $369.21 | -24.8% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -15.5% |
| A | Buy | 29 | 72% | $64.69 | -42.7% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -49.9% |
| MTD | Hold | 21 | 43% | $170.43 | -86.5% |
| ILMN | Hold | 28 | 54% | $169.36 | +34.2% |
| WAT | Buy | 28 | 57% | $189.60 | -37.3% |
| WST | Strong Buy | 23 | 78% | $136.24 | -44.8% |